Cypherpunk Technologies Inc. Common Stock (CYPH) Stock Price

CYPHStock

$1.64+463.76%52W

Market Cap$176.73M

P/E—

PEG Ratio—

Div yield—

Beta0.93

CYPH Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)152.08%

Price vs S&P 500 (4W)170.52%

VGM Score71.43

Book Value / Share (Quarterly)$0.90

Indicated Dividend (Annual)$0.00

Cash Flow / Share (Quarterly)$-0.39

Price vs S&P 500 (YTD)32.87%

Net Profit Margin (TTM)-2705.80%

EPS (TTM)$-0.69

10-Day Avg Trading Volume8.87M

EPS Excl Extra (TTM)$-0.69

EPS (Annual)$-1.80

ROI (Annual)-192.75%

Cash / Share (Quarterly)$0.07

P/E Basic Excl Extra (TTM)26.49x

ROA (Last FY)-137.52%

EBITD / Share (TTM)$-0.29

ROE (5Y Avg)-103.49%

Operating Margin (TTM)-2761.73%

Cash Flow / Share (Annual)$-0.52

P/B Ratio0.81x

P/B Ratio (Quarterly)0.85x

Net Income / Employee (Annual)$-11,259,200

Net Interest Coverage (TTM)-97.81x

ROA (TTM)-80.72%

EPS Incl Extra (Annual)$-1.80

Current Ratio (Annual)35.56x

Quick Ratio (Quarterly)27.02x

3-Month Avg Trading Volume4.49M

52-Week Price Return463.76%

P/E Incl Extra (TTM)26.49x

Revenue / Employee (TTM)$0

P/S Ratio (Annual)45.66x

Asset Turnover (Annual)0.01x

52-Week High$3.70

EPS Excl Extra (Annual)$-1.80

26-Week Price Return163.32%

Quick Ratio (Annual)35.55x

13-Week Price Return28.24%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)27.28x

Enterprise Value$61.80M

Asset Turnover (TTM)0.02x

Revenue / Employee (Annual)$0

Pretax Margin (Annual)-2707.40%

Cash / Share (Annual)$0.17

3-Month Return Std Dev176.90%

Net Income / Employee (TTM)$-9,484,800

ROE (Last FY)-192.75%

Net Interest Coverage (Annual)-0.06x

EPS Basic Excl Extra (Annual)$-1.80

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-0.69

ROI (TTM)-92.42%

P/S Ratio (TTM)45.66x

Revenue / Share (Annual)$0.00

Price vs S&P 500 (52W)445.45%

P/E Ratio (TTM)26.49x

Year-to-Date Return44.83%

5-Day Price Return108.59%

EPS Normalized (Annual)$-1.80

ROA (5Y Avg)-82.39%

Net Profit Margin (Annual)-2705.80%

Month-to-Date Return184.46%

EBITD / Share (Annual)$-1.87

Operating Margin (Annual)-2761.73%

ROI (5Y Avg)-103.49%

P/E Excl Extra (TTM)26.49x

EPS Basic Excl Extra (TTM)$-0.69

P/B Ratio (Annual)0.43x

Pretax Margin (TTM)-2707.40%

Book Value / Share (Annual)$1.83

Price vs S&P 500 (13W)25.45%

Beta0.93x

Revenue / Share (TTM)$0.00

ROE (TTM)-92.42%

52-Week Low$0.27

vGradeC

mGradeA

vgmGradeB

CYPH Earnings Surprise History

Q2 25-0.40est. -0.29

Q3 25-0.08est. -0.24

Q1 26-0.46est. —

Q2 26-0.02est. -0.03

CYPH Analyst Recommendations

Feb 2026

Mar 2026

Jul 2026

Aug 2026

2.17

4.14

Industry Peers — Pharmaceuticals(571)

Symbol	Value Score	Growth Score	Momentum Score	Price
CYPHCypherpunk Technologies Inc. Common Stock	C	—	A	$1.64
LLYEli Lilly & Co.	D	B	B	$1233.66
JNJJohnson & Johnson	D	C	B	$273.14
ABBVABBVIE INC.	D	C	B	$265.79
MRKMerck & Co., Inc.	D	C	A	$156.45
NVSNovartis AG	C	C	C	$159.98
AZNAstraZeneca PLC	C	B	C	$169.66
NVONovo-Nordisk A/S	B	C	C	$48.66
ABTAbbott Laboratories	C	C	B	$116.13
PFEPfizer Inc.	C	D	C	$28.57
VRTXVertex Pharmaceuticals Inc	D	C	B	$552.85
BMYBristol-Myers Squibb Co.	B	B	B	$67.92
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	C	C	$46.02
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	B	C	C	$52.07
REGNRegeneron Pharmaceuticals Inc	C	C	B	$833.56
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	C	$18.35
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	C	$38.10
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	C	$376.37
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	B	$62.07
ALNYAlnylam Pharmaceuticals, Inc.	D	A	D	$240.08
ZTSZOETIS INC.	B	C	D	$77.29
INSMInsmed, Inc.	F	A	C	$123.89
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	$36.47
UTHRUnited Therapeutics Corp	C	C	C	$518.53
GMABGenmab A/S ADS	C	C	B	$34.36
VTRSViatris Inc. Common Stock	B	C	B	$16.72
JAZZJazz Pharmaceuticals, Inc.	B	C	B	$260.23
ASNDAscendis Pharma A/S Ordinary Share	D	A	C	$252.99
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	$80.40
CORTCorcept Therapeutics Inc.	F	C	A	$123.57
BMRNBioMarin Pharmaceuticals Inc	C	C	C	$66.12
ARWRArrowhead Research Corporation	D	A	B	$88.88
ELANElanco Animal Health Incorporated Common Stock	C	B	B	$25.09
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	C	$512.16
CYTKCytokinetics Inc.	F	D	B	$77.46
AXSMAxsome Therapeutics, Inc	D	B	C	$205.48
SMMTSummit Therapeutics Inc. Common Stock	F	—	D	$13.36
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	$63.57
ABVXAbivax SA American Depositary Shares	—	—	C	$117.93
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	D	C	$12.34
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	$368.02
NUVLNuvalent, Inc. Class A Common Stock	—	—	B	$123.96
PTGXProtagonist Therapeutics, Inc	F	B	A	$150.59
SYRESpyre Therapeutics, Inc. Common Stock	—	—	A	$107.36
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	$84.86
TGTXTG Therapeutics, Inc.	D	B	A	$55.42
ALKSAlkermes Inc. plc	D	C	B	$49.21
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	$113.35
ORKAOruka Therapeutics, Inc. Common Stock	F	—	A	$101.82
BLTEBelite Bio, Inc American Depositary Shares	—	—	B	$161.68
COGTCogent Biosciences, Inc. Common Stock	F	—	B	$36.80

About Cypherpunk Technologies Inc. Common Stock

Cypherpunk Technologies Inc develops novel therapies for cancer patients while maintaining a digital asset treasury concentrated in Zcash. The company combines oncology research and drug development with cryptocurrency asset management.